News

Optimer said fidaxomicin is the first in a new class of antibiotics called macrocycles, which inhibit the bacterial enzyme RNA polymerase, resulting in the rapid killing of C

For the fourth quarter of 2010, the company posted a net income of $236m, or $0.15 per diluted share, compared to a net loss of $1.07bn, or $0.71

The company also reported that the first patient within the trial has been successfully genotyped and treatment has been initiated. LGC is collaborating with researchers from six European

Immunocytokine hu14.18-IL2 – an investigational antibody-based biologic, met drug development endpoints in a Phase II study involving certain paediatric neuroblastoma subjects, following which it has progressed to a

The formula is the latest addition to the Nestle Peptamen product family. Nestle HealthCare Nutrition has developed it with a unique protein-to-calorie ratio to help meet the protein

The research collaboration will start with the examination of the seven transporters cited by the International Transporter Consortium and the FDA as the most clinically relevant to transporter-related

Lixisenatide, a glucagon-like peptide-1 agonist (GLP-1), is in development for the treatment of patients with type 2 diabetes mellitus. Sanofi-aventis claims that GetGoal-X is the first head-to-head study

Camposomes are phospholipid nanoencapsulated camptothecins used to treat pancreatic and other cancers. The subcontract is in support of the National Cancer Institute (NCI) Alliance for Nanotechnology, and the

Paladin’s product line includes both over-the-counter (OTC) and prescription drugs such as Zincofax for diaper rash, Anbesol for teething, Cerumol for ear wax removal, Twinject for anaphylaxis, and